IMP Production Facility

Careful management is a prerequisite for successful, high-quality trials. Drug candidates must be produced, stored and administered correctly by a skilled practitioner to ensure safety and efficacy.

We provide comprehensive support solutions for all aspects of IMP trials. Each clinical trial will include a study specific production and/or dispensing protocol, created and executed in collaboration with the study sponsor, and our good manufacturing practice (GMP) authorized facility in Belgium ensures the efficient manufacture of IMP in the small volumes required for early phase trials.

We offer a broad and continuously expanding range of manufacturing services. Our modern production facility minimizes extraneous contamination, cross-contamination, error risks and general adverse hazards from product quality. We also have separate class D-C-B preparation rooms and, with continuous electronic monitoring systems in place, we can control particulate, temperature, humidity and overpressure.

SGS is recognized as the benchmark for quality and integrity in early phase clinical trials. Whatever your requirements, we have the capabilities in place to help you reduce risk while ensuring optimal outcomes from your trial.